Lyell Immunopharma, Inc. (LYEL)
21.78
+0.09
(+0.41%)
USD |
NASDAQ |
Apr 07, 16:00
21.68
-0.10
(-0.46%)
After-Hours: 20:00
Lyell Immunopharma Shareholders Equity (Quarterly) : 248.20M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Fortress Biotech, Inc. | 49.87M |
| Oramed Pharmaceuticals, Inc. | 199.74M |
| Climb Bio, Inc. | 160.48M |
| Moderna, Inc. | 8.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 340.05M |
| Total Liabilities (Quarterly) | 91.85M |
| Debt to Equity Ratio | 0.2055 |
| Current Ratio | 5.281 |
| Net Debt Paydown Yield | 0.33% |